Company Filing History:
1 out of 1,271 
1 out of 8 Years Active: 1997
Title: Mark Manax: Innovator in Retroviral Treatment
Introduction
Mark Manax is a notable inventor based in Laurel, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of retroviral infections. His innovative work has led to the development of a unique compound that holds promise for medical applications.
Latest Patents
Mark Manax holds a patent for "Suksdorfin, analogs, compositions thereof, and methods for making and using these compounds." This patent includes compounds and methods for treating retroviral infections, described by a specific formula that outlines various chemical configurations and potential applications. The patent emphasizes the importance of stereoselectivity, which can be enhanced through catalytic asymmetric dihydroxylation.
Career Highlights
Throughout his career, Mark has worked with esteemed institutions such as the University of North Carolina at Chapel Hill and Biotech Research Laboratories. His experience in these organizations has allowed him to refine his research and contribute to advancements in biotechnology.
Collaborations
Mark has collaborated with notable colleagues, including Kuo-Hsiung Lee and Yoshiki Kashiwada. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Mark Manax's contributions to the field of retroviral treatment through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to inspire advancements in medical research and pharmaceutical development.